Hairy leukoplakia

From WikiMD's WELLNESSPEDIA


Hairy leukoplakia
Synonyms Oral hairy leukoplakia
Pronounce N/A
Specialty N/A
Symptoms White patch on the tongue
Complications None
Onset Sudden
Duration Chronic
Types N/A
Causes Epstein–Barr virus (EBV) infection
Risks Immunosuppression, HIV/AIDS
Diagnosis Clinical examination, Biopsy
Differential diagnosis Oral candidiasis, Leukoplakia, Lichen planus
Prevention Antiretroviral therapy
Treatment Antiviral medication, Topical therapy
Medication N/A
Prognosis Benign
Frequency Common in HIV/AIDS patients
Deaths N/A


Hairy leukoplakia is a medical condition often associated with immunocompromised individuals, particularly those with HIV/AIDS. It is characterized by white patches on the side of the tongue, which have a hairy or corrugated appearance.

Etiology[edit]

Hairy leukoplakia is caused by the Epstein-Barr virus (EBV), a type of herpesvirus. The virus infects the cells on the surface of the tongue, leading to the characteristic white patches.

Symptoms[edit]

The primary symptom of hairy leukoplakia is the presence of white patches on the side of the tongue. These patches cannot be scraped off and may have a hairy or corrugated appearance. Other symptoms may include a sore throat, difficulty swallowing, and a feeling of discomfort in the mouth.

Diagnosis[edit]

Diagnosis of hairy leukoplakia is typically made based on the appearance of the tongue. In some cases, a biopsy may be performed to confirm the diagnosis and rule out other conditions, such as oral thrush or oral cancer.

Treatment[edit]

Treatment for hairy leukoplakia primarily involves managing the underlying condition that has led to the weakened immune system. This may involve antiretroviral therapy for individuals with HIV/AIDS. In some cases, antiviral medications may be used to directly target the Epstein-Barr virus.

Prognosis[edit]

The prognosis for individuals with hairy leukoplakia is generally good, particularly if the underlying condition is well-managed. However, the presence of hairy leukoplakia can be an indicator of a weakened immune system, and may signal the progression of HIV to AIDS in individuals with HIV.

See also[edit]

Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.